Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Giuseppe Leone: The Evolving Treatment Landscape of Adult ITP
Nov 20, 2026, 14:37

Giuseppe Leone: The Evolving Treatment Landscape of Adult ITP

Giuseppe Leone, Editor in Chief on Mediterranean Journal of Hematology and Infectious Diseases, Faculty of Medicine, Università Cattolica, shared a post on LinkedIn about a recent article by Massimo Martino et al., published in Mediterranean Journal of Hematology and Infectious Diseases, adding:

“For decades, treatment relied on corticosteroids as first-line therapy, followed by a limited range of second-line options including thrombopoietin receptor agonists (TPO-RAs), rituximab, splenectomy, and, more recently, fostamatinib.

Growing understanding of the immune mechanisms underlying both accelerated platelet destruction and impaired platelet production has expanded the therapeutic landscape. and in the last few years new dugs have been introduced.

This narrative review, free online in the MJHID, focuses on primary ITP in adults and summarizes current evidence on epidemiology, pathophysiology, clinical and humanistic burden, established therapies, and emerging targeted treatments.”

Title: Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Biologic Therapies

Authors: Massimo Martino, Laura Giordano, Maria Bruna Greve, Violetta Marafioti, Caterina Alati

Giuseppe Leone: The Evolving Treatment Landscape of Adult ITP

Stay updated with Hemostasis Today.